Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "Negatives and Possible Solutions"

"if an MA is done.... but with NO new licensing revenue, we would still be in the same predicament IMO"



If PTSC can acquire a company that has a STEADY $30M annual positive cash flow that it can COUNT on, and potentially grow, and there were NO new signings EVER, do you really think that we would be in the same predicament?



I agree, M&A PLUS additional signings is better, but I certainly think that a steady positive cash flow, that can be improved and leveraged again into other M&A's, even if there were no more MMP deals were signed, puts us on better footing than we are now. And even then, we KNOW there will be additoinal MMP license deals, we just don't know when and for how much.

Share
New Message
Please login to post a reply